Publications — Radcliffe Department of Medicine

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Empiric Cryoprecipitate Transfusion in Patients with Severe Hemorrhage: Results from the US Experience in the International CRYOSTAT-2 Trial.

Van Gent J-M. et al, (2024), J Am Coll Surg, 238, 636 - 643

Iron Deficiency in Anemic Children Surviving Critical Illness: Post Hoc Analysis of a Single-Center Prospective Cohort in Canada, 2019-2022.

Du Pont-Thibodeau G. et al, (2024), Pediatr Crit Care Med, 25, 344 - 353

Management and outcomes of women with low fibrinogen concentration during pregnancy or immediately postpartum: A UK national population-based cohort study.

Diguisto C. et al, (2024), Acta Obstet Gynecol Scand

The 2023 AABB international guidelines for red blood cell transfusions: What is new?

Pagano MB. et al, (2024), Transfusion

Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Results of a pilot randomized trial RBC-ENHANCE.

Buckstein R. et al, (2024), Transfusion

Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline.

Kulasekararaj A. et al, (2024), Br J Haematol

Rethinking the transfusion pathway in myelodysplastic syndromes: Study protocol for a novel randomized feasibility n-of-1 trial of weekly-interval red cell transfusion in myelodysplastic syndromes.

Mo A. et al, (2024), Transfusion

Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies.

Buckstein R. et al, (2023), Am J Hematol

Intravenous albumin in cardiac and vascular surgery: a systematic review and meta-analysis.

Skubas NJ. et al, (2023), Br J Anaesth

Iron and erythropoietin to heal and recover after intensive care (ITHRIVE): A pilot randomised clinical trial

Litton E. et al, (2023), Critical Care and Resuscitation, 25, 201 - 206

Early and Empirical High-Dose Cryoprecipitate for Hemorrhage After Traumatic Injury: The CRYOSTAT-2 Randomized Clinical Trial.

Davenport R. et al, (2023), JAMA, 330, 1882 - 1891

Red Blood Cell Transfusion: 2023 AABB International Guidelines.

Carson JL. et al, (2023), JAMA, 330, 1892 - 1902

Harnessing the potential of data-driven strategies to optimise transfusion practice.

Evans HG. et al, (2023), Br J Haematol

The SWiFT trial (Study of Whole Blood in Frontline Trauma)-the clinical and cost effectiveness of pre-hospital whole blood versus standard care in patients with life-threatening traumatic haemorrhage: study protocol for a multi-centre randomised controlled trial.

Smith JE. et al, (2023), Trials, 24

Machine learning in transfusion medicine: A scoping review.

Maynard S. et al, (2023), Transfusion

E-learning in transfusion medicine: A scoping review.

Al-Riyami AZ. et al, (2023), Transfusion

An analysis of quality of life and functional outcomes as reported in randomized trials for red cell transfusions.

Pagano MB. et al, (2023), Transfusion

The ongoing dilemma of prophylactic platelet transfusions pre-procedure and the development of evidence-based recommendations.

Stanworth SJ. et al, (2023), Transfus Med

The ISTH SSC subcommittee on Hemostatic Management of Patients with Liver Disease: goals, ambitions, and call for collaboration: reply.

Lisman T. et al, (2023), J Thromb Haemost, 21, 2632 - 2633

Prophylactic Platelet Transfusion: Is There Evidence of Benefit, Harm, or No Effect?

Maier CL. et al, (2023), Transfus Med Rev

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?